Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Obesity × exemestane × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Breast Neoplasms 67 Neoplasm Metastasis 6 Breast Neoplasms, Male 3 Neoplasms 2 Arthralgia 2 Triple Negative Breast Neoplasms 1 Sleep Wake Disorders 1 Skin Diseases 1 Post Menopausal Women With Early Breast Cancer 1 Pain 1 Obesity 1 Metastatic Beast Cancer 1 Lymphoma 1 Lethal Congenital Contracture Syndrome 2 1 Invasive Early Breast Cancer 1 Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 1 Fatigue 1 Estrogen-receptor Positive Invasive Metastatic Breast Cancer 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Advanced Breast Carcinoma 1 Advanced Breast Cancer 1

Interventions

Metformin 5 Exenatide 4 Vitamin D 2 penclomedine 1 licogliflozin 1 exemestane 1 dapagliflozin 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Therapeutics 1 Testosterone 1 Taxes 1 Tamoxifen 1 Sugars 1 Sugammadex 1 Sodium-Glucose Transporter 2 Inhibitors 1 Resistance Training 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Qsymia 1 Progesterone 1 Paclitaxel 1 Observation 1 Naltrexone 1 Methods 1 Letrozole 1 Glucocorticoids 1 Glucagon-Like Peptide 1 1 Excitatory Amino Acids 1 Estrogens 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01896050 2016-06-28

LOGRIBMET

University of Michigan Rogel Cancer Center

115 enrolled 14 charts

Breast Neoplasms, Obesity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡